Market Overview:
The global marine-derived pharmaceuticals market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for marine-derived pharmaceuticals due to their high efficacy and safety profile. In addition, the growing awareness about the benefits of marine-derived pharmaceuticals is also contributing to the growth of this market. The global marine-derived pharmaceuticals market can be segmented on the basis of type, application, and region.
Product Definition:
A marine-derived pharmaceutical is a drug that is derived from the ocean. Marine-derived pharmaceuticals are important because they can be used to treat a variety of diseases.
Phenols:
Phenols is a group of chemical compounds that includes natural as well as artificial products. Natural phenols are extracted from plants, which include catechol, resorcinol, andVID e. Artificial phenols are manufactured by the chemical synthesis of alkyl halides with bromine or chlorine; for instance, diphenyl borate (DIB) is an artificial form of phenol used in the pharmaceutical industry to treat warts and veruccae.
Steroids:
Steroids are organic compounds synthesized in the laboratory. They are man-made derivatives of hormones, used as medicines to treat diseases such as asthma and arthritis. Steroids can be administered through oral tablets, injections or implants depending on their type.
Application Insights:
The market is segmented by application into hospital pharmacies, retail pharmacies and online pharmacies. Hospital pharmacy held the largest share in 2017 owing to factors such as high usage of intravenous fluids and other pharmaceutical products that are used for a short-term basis. The growth of the hospital sector, especially in developing countries like India and China is expected to boost demand for marine-derived pharmaceuticals over the forecast period.
Retail pharmacy was estimated as the second largest segment due to increasing consumer preference for purchasing medicines from local stores rather than traveling to distant hospitals or medical centers. Moreover, growing penetration of e-commerce platforms has boosted product sales through online Pharmacies which accounted for 7% revenue share in 2017.
Regional Analysis:
Asia Pacific dominated the global market in 2017 and is expected to maintain its position over the forecast period. This can be attributed to increasing R&D investments by pharmaceutical companies, growing demand for medicines, and rising healthcare expenditure in this region. In addition, favorable government initiatives pertaining to marine-derived pharmaceuticals are also anticipated to propel growth during the forecast period.
Europe accounted for a significant share of revenue in 2017 owing to high product demand from countries such as Germany, France and U.K., which are majorly driven by medical applications of these products rather than their originator fish species (Squalus vulgaris).
Growth Factors:
- Increasing demand for marine-derived pharmaceuticals due to their therapeutic properties
- Growing awareness about the benefits of marine-derived pharmaceuticals
- Rising number of research and development activities in the field of marine-derived pharmaceuticals
- Technological advancements in the extraction and purification processes of marine-derived pharmaceuticals
- Growing investments by private and public sector players in the field of Marine-Derived Pharmaceuticals
Scope Of The Report
Report Attributes
Report Details
Report Title
Marine-derived Pharmaceuticals Market Research Report
By Type
Phenols, Steroids, Ethers, Peptides, Other
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Eli Lilly, Abbott, Bayer, Novartis, GlaxoSmithKline, PharmaMar, Sealife Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
161
Number of Tables & Figures
113
Customization Available
Yes, the report can be customized as per your need.
Global Marine-derived Pharmaceuticals Market Report Segments:
The global Marine-derived Pharmaceuticals market is segmented on the basis of:
Types
Phenols, Steroids, Ethers, Peptides, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Eli Lilly
- Abbott
- Bayer
- Novartis
- GlaxoSmithKline
- PharmaMar
- Sealife Pharma
Highlights of The Marine-derived Pharmaceuticals Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Phenols
- Steroids
- Ethers
- Peptides
- Other
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Marine-derived Pharmaceuticals Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Marine-derived pharmaceuticals are drugs that have been derived from marine sources. These include both natural products and synthetic compounds.
Some of the major players in the marine-derived pharmaceuticals market are Eli Lilly, Abbott, Bayer, Novartis, GlaxoSmithKline, PharmaMar, Sealife Pharma.
The marine-derived pharmaceuticals market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Marine-derived Pharmaceuticals Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Marine-derived Pharmaceuticals Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Marine-derived Pharmaceuticals Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Marine-derived Pharmaceuticals Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Marine-derived Pharmaceuticals Market Size & Forecast, 2018-2028
4.5.1 Marine-derived Pharmaceuticals Market Size and Y-o-Y Growth
4.5.2 Marine-derived Pharmaceuticals Market Absolute $ Opportunity
Chapter 5 Global Marine-derived Pharmaceuticals Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Marine-derived Pharmaceuticals Market Size Forecast by Type
5.2.1 Phenols
5.2.2 Steroids
5.2.3 Ethers
5.2.4 Peptides
5.2.5 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Marine-derived Pharmaceuticals Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Marine-derived Pharmaceuticals Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Marine-derived Pharmaceuticals Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Marine-derived Pharmaceuticals Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Marine-derived Pharmaceuticals Analysis and Forecast
9.1 Introduction
9.2 North America Marine-derived Pharmaceuticals Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Marine-derived Pharmaceuticals Market Size Forecast by Type
9.6.1 Phenols
9.6.2 Steroids
9.6.3 Ethers
9.6.4 Peptides
9.6.5 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Marine-derived Pharmaceuticals Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Online Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Marine-derived Pharmaceuticals Analysis and Forecast
10.1 Introduction
10.2 Europe Marine-derived Pharmaceuticals Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Marine-derived Pharmaceuticals Market Size Forecast by Type
10.6.1 Phenols
10.6.2 Steroids
10.6.3 Ethers
10.6.4 Peptides
10.6.5 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Marine-derived Pharmaceuticals Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Marine-derived Pharmaceuticals Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Marine-derived Pharmaceuticals Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Marine-derived Pharmaceuticals Market Size Forecast by Type
11.6.1 Phenols
11.6.2 Steroids
11.6.3 Ethers
11.6.4 Peptides
11.6.5 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Marine-derived Pharmaceuticals Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Marine-derived Pharmaceuticals Analysis and Forecast
12.1 Introduction
12.2 Latin America Marine-derived Pharmaceuticals Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Marine-derived Pharmaceuticals Market Size Forecast by Type
12.6.1 Phenols
12.6.2 Steroids
12.6.3 Ethers
12.6.4 Peptides
12.6.5 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Marine-derived Pharmaceuticals Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Marine-derived Pharmaceuticals Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Marine-derived Pharmaceuticals Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Marine-derived Pharmaceuticals Market Size Forecast by Type
13.6.1 Phenols
13.6.2 Steroids
13.6.3 Ethers
13.6.4 Peptides
13.6.5 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Marine-derived Pharmaceuticals Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Marine-derived Pharmaceuticals Market: Competitive Dashboard
14.2 Global Marine-derived Pharmaceuticals Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Eli Lilly
14.3.2 Abbott
14.3.3 Bayer
14.3.4 Novartis
14.3.5 GlaxoSmithKline
14.3.6 PharmaMar
14.3.7 Sealife Pharma
